Director, Marshall Institute of Interdisciplinary Research (MIIR)
Dr. Zijian Xie was named director of the Marshall Institute for Interdisciplinary Research in November 2013.
His laboratory is internationally recognized for its groundbreaking work to understand the behavior of cellular pathways and their relationship to cancer, renal disease and cardiac failure.
Xie holds international patents and patent applications on seven medical inventions resulting from his research. He has served as principal investigator, project leader or co-investigator on National Institutes of Health-funded projects totaling more than $10 million, and has established active international collaborations with total funding of more than $1 million. He has been involved with the creation of two spin-off companies from his research.
He is the author or co-author of more than 100 articles published in scientific journals, has authored a number of book chapters and has been invited to give numerous presentations as part of national and international conferences, symposia, seminars and visiting professorships. He serves as a regular member of NIH study sections and has chaired and co-organized several international symposia.
Dr. Xie came to Marshall from the faculty of the University of Toledo’s College of Medicine, where he was a professor of physiology, pharmacology and medicine, and served as the co-director of the M.D./Ph.D. program.
He earned a bachelor’s degree from the Nanjing College of Pharmacy in Nanjing, China, in 1982, a master’s degree in toxicology at the Chinese Academy of Medical Sciences in Beijing in 1984 and a doctorate in pharmacology at the Medical College of Ohio (now University of Toledo) in 1990.
read more
His laboratory is internationally recognized for its groundbreaking work to understand the behavior of cellular pathways and their relationship to cancer, renal disease and cardiac failure.
Xie holds international patents and patent applications on seven medical inventions resulting from his research. He has served as principal investigator, project leader or co-investigator on National Institutes of Health-funded projects totaling more than $10 million, and has established active international collaborations with total funding of more than $1 million. He has been involved with the creation of two spin-off companies from his research.
He is the author or co-author of more than 100 articles published in scientific journals, has authored a number of book chapters and has been invited to give numerous presentations as part of national and international conferences, symposia, seminars and visiting professorships. He serves as a regular member of NIH study sections and has chaired and co-organized several international symposia.
Dr. Xie came to Marshall from the faculty of the University of Toledo’s College of Medicine, where he was a professor of physiology, pharmacology and medicine, and served as the co-director of the M.D./Ph.D. program.
He earned a bachelor’s degree from the Nanjing College of Pharmacy in Nanjing, China, in 1982, a master’s degree in toxicology at the Chinese Academy of Medical Sciences in Beijing in 1984 and a doctorate in pharmacology at the Medical College of Ohio (now University of Toledo) in 1990.
×
About Zijian Xie
Dr. Zijian Xie was named director of the Marshall Institute for Interdisciplinary Research in November 2013.
His laboratory is internationally recognized for its groundbreaking work to understand the behavior of cellular pathways and their relationship to cancer, renal disease and cardiac failure.
Xie holds international patents and patent applications on seven medical inventions resulting from his research. He has served as principal investigator, project leader or co-investigator on National Institutes of Health-funded projects totaling more than $10 million, and has established active international collaborations with total funding of more than $1 million. He has been involved with the creation of two spin-off companies from his research.
He is the author or co-author of more than 100 articles published in scientific journals, has authored a number of book chapters and has been invited to give numerous presentations as part of national and international conferences, symposia, seminars and visiting professorships. He serves as a regular member of NIH study sections and has chaired and co-organized several international symposia.
Dr. Xie came to Marshall from the faculty of the University of Toledo’s College of Medicine, where he was a professor of physiology, pharmacology and medicine, and served as the co-director of the M.D./Ph.D. program.
He earned a bachelor’s degree from the Nanjing College of Pharmacy in Nanjing, China, in 1982, a master’s degree in toxicology at the Chinese Academy of Medical Sciences in Beijing in 1984 and a doctorate in pharmacology at the Medical College of Ohio (now University of Toledo) in 1990.
His laboratory is internationally recognized for its groundbreaking work to understand the behavior of cellular pathways and their relationship to cancer, renal disease and cardiac failure.
Xie holds international patents and patent applications on seven medical inventions resulting from his research. He has served as principal investigator, project leader or co-investigator on National Institutes of Health-funded projects totaling more than $10 million, and has established active international collaborations with total funding of more than $1 million. He has been involved with the creation of two spin-off companies from his research.
He is the author or co-author of more than 100 articles published in scientific journals, has authored a number of book chapters and has been invited to give numerous presentations as part of national and international conferences, symposia, seminars and visiting professorships. He serves as a regular member of NIH study sections and has chaired and co-organized several international symposia.
Dr. Xie came to Marshall from the faculty of the University of Toledo’s College of Medicine, where he was a professor of physiology, pharmacology and medicine, and served as the co-director of the M.D./Ph.D. program.
He earned a bachelor’s degree from the Nanjing College of Pharmacy in Nanjing, China, in 1982, a master’s degree in toxicology at the Chinese Academy of Medical Sciences in Beijing in 1984 and a doctorate in pharmacology at the Medical College of Ohio (now University of Toledo) in 1990.
| Present | Director, Marshall Institute of Interdisciplinary Research (MIIR), Marshall University | |
|
|
||
Disciplines
Contact Information
phone: 304-696-3852
Email: